Tomita N, Motomura S, Ishigatsubo Y
Department of Hematology, Fujieda Municipal General Hospital, Shizuoka, Japan.
Anticancer Drugs. 2001 Jan;12(1):7-8. doi: 10.1097/00001813-200101000-00002.
We report a case of pure red cell aplasia (PRCA) that resulted from interferon (IFN)-alpha therapy for chronic myelogenous leukemia. PRCA improved within 1 month after IFN-alpha was discontinued. This case indicates the involvement of IFN-alpha in the pathogenesis of PRCA.